SEBI ICDR regulations. Fair value, price band advisory, comparable analysis. IBBI Registered Valuer." /> SEBI ICDR regulations. Fair value, price band advisory, comparable analysis. IBBI Registered Valuer." /> SEBI ICDR regulations. Fair value, price band advisory, comparable analysis. IBBI Registered Valuer." />

Loading...

Pre-IPO Valuation Report India | Virtual Auditor

Quick answer: A pre-IPO valuation report establishes fair value for pre-listing share issuances, ESOP grants and pre-IPO placements. It reconciles DCF and market-multiple approaches with the expected IPO pricing band, and supports Companies Act pricing requirements, income-tax documentation and investor negotiations in the run-up to listing.

Pre-IPO valuation for mainboard & SME IPO. SEBI ICDR regulations. Fair value, price band advisory, comparable analysis. IBBI Registered Valuer.

Last reviewed: July 2026 by CA V. Viswanathan (FCA, ACS, CFE, IBBI Registered Valuer)

Pre-IPO Valuation — Where Private Value Meets Public Scrutiny

A pre-IPO valuation sits at the most scrutinised point in a company's life. In the twelve to twenty-four months before listing, a company typically raises a pre-IPO placement, cleans up its cap table, finalises ESOP grants, and prepares the offer document — every one of which turns on a defensible valuation that must now satisfy not just investors but SEBI, the merchant bankers running the issue, and the auditors signing the accounts. The tolerance for the loose, forward-looking numbers acceptable at Series A collapses here: everything must be evidenced, consistent across documents, and capable of surviving the regulator's and the eventual public market's judgement.

The SEBI ICDR Pricing Framework

Public-issue pricing is governed by the SEBI (Issue of Capital and Disclosure Requirements) Regulations. The report has to work within its architecture:

ElementWhat ICDR requires
Pricing methodBook-building (price band, demand discovery) or fixed price; most large issues use book-building
Basis of issue priceThe offer document must justify the price with KPIs, accounting ratios and comparison to listed peers
Pre-IPO placementPermitted, but shares so allotted are subject to lock-in and reduce the fresh issue size correspondingly
Promoter and pre-issue capital lock-inMinimum promoter contribution locked in; other pre-issue capital locked in for prescribed periods

Crucially, the offer document's "Basis for Issue Price" section must reconcile the price band to fundamentals — earnings, net worth, sector multiples — so a pre-IPO valuation that cannot be defended on those metrics becomes a disclosure liability rather than a marketing asset.

Anchor and Pre-IPO Investors — Lock-Ins That Shape the Value

Two investor cohorts price in just before the public and carry lock-in restrictions that a valuation must account for:

  1. Pre-IPO placement investors: buy in months before the issue at a negotiated price; their shares are locked in post-listing, and the placement price sets an important reference point the offer price cannot ignore.
  2. Anchor investors: institutional investors allotted shares a day before the issue opens, at or within the price band, to signal confidence. Their allocation carries a staggered lock-in — a portion for a shorter period and the balance for longer — reflecting SEBI's tightening of anchor lock-ins to reduce immediate post-listing selling.
  3. Discount for lock-in: a valuation supporting a pre-IPO placement should reflect that the shares cannot be sold freely for the lock-in period — a marketability discount that a naive "IPO price minus a bit" approach misses.

Price Band vs Fair Value — Two Related but Distinct Numbers

Founders often conflate the IPO price band with fair value; they are related but not identical:

  • Fair value is the intrinsic, methodology-driven estimate — DCF and comparable-company analysis — of what the business is worth.
  • The price band is a marketing and demand-discovery construct, set with the merchant bankers to attract subscription, generate an orderly aftermarket, and leave something on the table for public investors. It is often set at a modest discount to fair value precisely to ensure the issue is fully subscribed and trades up on listing.
  • The reconciliation between them belongs in the working file: the fair-value analysis justifies that the band is not excessive, protecting against the disclosure risk of an over-priced issue.

The Pre-IPO Valuation Timeline — What Happens When

A disciplined listing candidate treats valuation as a programme, not a one-off report:

  1. T-24 to T-18 months: baseline fair-value model built; historical ESOP grant prices reconciled; any cheap-stock exposure identified while there is still time to manage it.
  2. T-18 to T-12 months: pre-IPO placement rounds priced off a refreshed valuation; restated Ind AS financials begin to crystallise the share-based-payment expense the offer document will carry.
  3. T-12 to T-6 months: merchant bankers appointed; the fair-value work is stress-tested against listed-peer multiples that will anchor the "Basis for Issue Price" section; final ESOP grants priced with heightened care.
  4. T-6 months to listing: price band set with the bankers; the valuation file supports the band justification; anchor allocation and lock-in mechanics finalised.

Companies that begin this sequence late compress every step into diligence season — which is by far the most expensive and highest-pressure possible time to discover a valuation inconsistency in the grant history or placement pricing.

Cheap-Stock Scrutiny of Pre-IPO ESOP Grants

The single most common pre-IPO valuation problem is cheap stock: options and shares granted to employees and executives in the run-up to listing at prices well below the eventual IPO value.

Why auditors and bankers hunt for it: options granted cheaply shortly before an IPO create additional share-based-compensation expense that must be recognised in the financial statements in the offer document, and they invite questions about whether the grant valuations were genuine. A steep jump from the last ESOP grant price to the IPO price, without intervening business events to explain it, is a red flag. A disciplined trail of contemporaneous merchant-banker perquisite valuations, each supporting the grants priced off it, is the defence — reconstructing it during IPO diligence is painful and sometimes impossible.

We prepare pre-IPO ESOP grant valuations on a contemporaneous basis, and where a listing is on the horizon, we build the reconciliation between historical grant prices and the emerging IPO value so the "Basis for Issue Price" and the share-based-payment note tell one coherent story.

Fees

ServiceFee (from)
Pre-IPO placement valuation report₹1,50,000
Fair value vs price-band reconciliation memo₹75,000
Pre-IPO ESOP grant valuation (per grant)₹40,000
Cheap-stock analysis and trail reconstructionScoped per company

Why Choose Virtual Auditor?

  • Fellow Chartered Accountant (FCA) with 14+ years experience
  • IBBI Registered Valuer (IBBI/RV/03/2019/12333)
  • Certified Fraud Examiner (CFE)
  • Associate Company Secretary (ACS)
  • Offices in Chennai, Bangalore, and Mumbai
  • 100+ complex valuations completed

Our Approach

We combine deep regulatory expertise with AI-powered tools to deliver accurate, defensible, and timely results. Every engagement is led by CA V. Viswanathan, ensuring senior-level attention.

Contact Us

Chennai (HQ): G-131, Ground Floor, Phase 3, Spencer Plaza Mall, Anna Salai, Chennai 600002. Phone: +91 99622 60333.

Bangalore: 7th Floor, Mahalakshmi Chambers, 29, MG Road, Bangalore 560001. Phone: +91 95139 39333.

Mumbai: Workafella, AK Estate, SV Road, Goregaon West, Mumbai 400062. Phone: +91 77000 89597.

Strategic Business & Compliance Insights

Frequently Asked Questions

What is a pre-IPO valuation report?
It is a valuation prepared in the twelve to twenty-four months before a listing, used to price a pre-IPO placement, support ESOP grants, and inform the offer document. It sits at the most scrutinised point in a company's life because it must satisfy investors, the merchant bankers managing the issue, the auditors signing the accounts, and SEBI. Unlike earlier-stage valuations, it must be fully evidenced, consistent across every document, and capable of withstanding both regulatory review and the public market's judgement on listing.
How does SEBI ICDR affect IPO pricing?
The SEBI (Issue of Capital and Disclosure Requirements) Regulations govern how a public issue is priced — through book-building with a price band or at a fixed price — and require the offer document to justify the price in a 'Basis for Issue Price' section using KPIs, accounting ratios and listed-peer comparison. Pre-IPO placements are permitted but their shares are locked in and reduce the fresh issue size. A valuation that cannot be defended on the required fundamentals becomes a disclosure liability rather than a marketing asset.
What is the difference between the IPO price band and fair value?
Fair value is the intrinsic, methodology-driven estimate of the business's worth from DCF and comparable-company analysis. The price band is a marketing and demand-discovery construct set with the merchant bankers, often at a modest discount to fair value to ensure full subscription and a healthy listing. They are related but distinct: the fair-value analysis belongs in the working file to demonstrate the band is not excessive, protecting the company and its directors against the disclosure risk of an over-priced issue.
What are anchor investor lock-ins?
Anchor investors are institutions allotted shares one day before the public issue opens, at or within the price band, to signal confidence and anchor demand. Their allocation carries a staggered lock-in — a portion released after a shorter period and the balance held for longer — reflecting SEBI's tightening of anchor lock-ins to curb immediate post-listing selling. Because anchor and pre-IPO placement shares cannot be freely sold for their lock-in periods, a valuation supporting placement pricing should reflect a corresponding marketability discount.
What is cheap-stock scrutiny in a pre-IPO context?
Cheap-stock scrutiny is the review by auditors and merchant bankers of whether options or shares were granted to employees and executives shortly before the IPO at prices well below the eventual listing value. Cheaply granted options create extra share-based-compensation expense that must be recognised in the offer-document financials and raise questions about the genuineness of the grant valuations. A large unexplained jump from the last grant price to the IPO price is a red flag; a trail of contemporaneous valuations is the defence.
How do we defend our pre-IPO ESOP grant prices?
With a disciplined trail of contemporaneous merchant-banker perquisite valuations, each supporting the grants priced off it, and a documented reconciliation between historical grant prices and the emerging IPO value that ties intervening price increases to real business events. Reconstructing this during IPO diligence is painful and sometimes impossible, so it should be built as grants are made. Done properly, the 'Basis for Issue Price' section and the share-based-payment note in the financials tell one coherent, defensible story.
Does a pre-IPO placement price set the IPO price?
It does not set it, but it is a powerful reference the offer price cannot ignore. A pre-IPO placement completed months earlier at a negotiated price, with its shares locked in post-listing, establishes an evidenced value point that the merchant bankers and the market will weigh when the band is set. A large gap between a recent placement price and the IPO band invites questions. The placement valuation should therefore be robust and consistent with the eventual pricing narrative, not merely opportunistic.